vs
Primo Brands Corp（PRMB）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Primo Brands Corp的季度营收约是Steris的1.1倍（$1.6B vs $1.5B），Steris净利率更高（12.9% vs 1.7%，领先11.2%），Steris同比增速更快（9.2% vs 0.8%），过去两年Primo Brands Corp的营收复合增速更高（19.7% vs 15.8%）
Primo Brands Corp是一家美加合资饮用水企业，主营多规格桶装水、饮水机、自助补水设备及净水家电，总部位于美国佛罗里达州坦帕市，服务覆盖美国、加拿大、欧洲及以色列的住宅与商业客户。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
PRMB vs STE — 直观对比
营收规模更大
PRMB
是对方的1.1倍
$1.5B
营收增速更快
STE
高出8.4%
0.8%
净利率更高
STE
高出11.2%
1.7%
两年增速更快
PRMB
近两年复合增速
15.8%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.5B |
| 净利润 | $27.3M | $192.9M |
| 毛利率 | 28.6% | 43.8% |
| 营业利润率 | 8.5% | 18.3% |
| 净利率 | 1.7% | 12.9% |
| 营收同比 | 0.8% | 9.2% |
| 净利润同比 | -4.9% | 11.2% |
| 每股收益（稀释后） | $0.07 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRMBSTE
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.8B | $1.5B | ||
| Q2 25 | $1.7B | $1.4B | ||
| Q1 25 | $1.6B | $1.5B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $0 | $1.3B | ||
| Q2 24 | $1.3B | $1.3B |
净利润PRMBSTE
| Q1 26 | $27.3M | — | ||
| Q4 25 | $-13.0M | $192.9M | ||
| Q3 25 | $16.8M | $191.9M | ||
| Q2 25 | $27.6M | $177.4M | ||
| Q1 25 | $28.7M | $145.7M | ||
| Q4 24 | — | $173.5M | ||
| Q3 24 | $-2.0K | $150.0M | ||
| Q2 24 | $54.5M | $145.4M |
毛利率PRMBSTE
| Q1 26 | 28.6% | — | ||
| Q4 25 | 27.7% | 43.8% | ||
| Q3 25 | 29.9% | 44.2% | ||
| Q2 25 | 31.3% | 45.1% | ||
| Q1 25 | 32.3% | 43.3% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | — | 43.6% | ||
| Q2 24 | 32.7% | 44.7% |
营业利润率PRMBSTE
| Q1 26 | 8.5% | — | ||
| Q4 25 | 1.2% | 18.3% | ||
| Q3 25 | 8.3% | 18.2% | ||
| Q2 25 | 6.5% | 17.7% | ||
| Q1 25 | 9.5% | 14.6% | ||
| Q4 24 | — | 17.9% | ||
| Q3 24 | — | 16.5% | ||
| Q2 24 | 12.1% | 14.5% |
净利率PRMBSTE
| Q1 26 | 1.7% | — | ||
| Q4 25 | -0.8% | 12.9% | ||
| Q3 25 | 1.0% | 13.1% | ||
| Q2 25 | 1.6% | 12.8% | ||
| Q1 25 | 1.8% | 9.8% | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | 4.1% | 11.4% |
每股收益（稀释后）PRMBSTE
| Q1 26 | $0.07 | — | ||
| Q4 25 | $-0.03 | $1.96 | ||
| Q3 25 | $0.04 | $1.94 | ||
| Q2 25 | $0.07 | $1.79 | ||
| Q1 25 | $0.08 | $1.48 | ||
| Q4 24 | — | $1.75 | ||
| Q3 24 | $-20.00 | $1.51 | ||
| Q2 24 | $0.25 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $423.7M |
| 总债务越低越好 | $5.2B | $1.9B |
| 股东权益账面价值 | $3.0B | $7.2B |
| 总资产 | $10.6B | $10.6B |
| 负债/权益比越低杠杆越低 | 1.74× | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资PRMBSTE
| Q1 26 | — | — | ||
| Q4 25 | $376.7M | $423.7M | ||
| Q3 25 | — | $319.2M | ||
| Q2 25 | — | $279.7M | ||
| Q1 25 | — | $171.7M | ||
| Q4 24 | — | $155.2M | ||
| Q3 24 | — | $172.2M | ||
| Q2 24 | — | $198.3M |
总债务PRMBSTE
| Q1 26 | $5.2B | — | ||
| Q4 25 | $5.2B | $1.9B | ||
| Q3 25 | $5.1B | $1.9B | ||
| Q2 25 | $5.1B | $1.9B | ||
| Q1 25 | $5.0B | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B |
股东权益PRMBSTE
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $7.2B | ||
| Q3 25 | $3.2B | $7.0B | ||
| Q2 25 | $3.2B | $7.0B | ||
| Q1 25 | $3.3B | $6.6B | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | $-2.0K | $6.6B | ||
| Q2 24 | $-296.8M | $6.4B |
总资产PRMBSTE
| Q1 26 | $10.6B | — | ||
| Q4 25 | $10.6B | $10.6B | ||
| Q3 25 | $11.0B | $10.4B | ||
| Q2 25 | $11.0B | $10.4B | ||
| Q1 25 | $11.0B | $10.1B | ||
| Q4 24 | — | $10.0B | ||
| Q3 24 | $0 | $10.2B | ||
| Q2 24 | — | $10.1B |
负债/权益比PRMBSTE
| Q1 26 | 1.74× | — | ||
| Q4 25 | 1.72× | 0.27× | ||
| Q3 25 | 1.61× | 0.27× | ||
| Q2 25 | 1.57× | 0.27× | ||
| Q1 25 | 1.51× | 0.29× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $103.8M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | — | $199.5M |
| 自由现金流率自由现金流/营收 | — | 13.3% |
| 资本支出强度资本支出/营收 | 2.9% | 6.6% |
| 现金转化率经营现金流/净利润 | 3.80× | 1.55× |
| 过去12个月自由现金流最近4个季度 | — | $917.1M |
8季度趋势，按日历期对齐
经营现金流PRMBSTE
| Q1 26 | $103.8M | — | ||
| Q4 25 | $203.1M | $298.2M | ||
| Q3 25 | $283.4M | $287.8M | ||
| Q2 25 | $155.0M | $420.0M | ||
| Q1 25 | $38.8M | $260.8M | ||
| Q4 24 | — | $332.8M | ||
| Q3 24 | $0 | $250.7M | ||
| Q2 24 | $102.5M | $303.7M |
自由现金流PRMBSTE
| Q1 26 | — | — | ||
| Q4 25 | $57.3M | $199.5M | ||
| Q3 25 | $167.7M | $201.3M | ||
| Q2 25 | $101.1M | $326.4M | ||
| Q1 25 | $-23.2M | $189.9M | ||
| Q4 24 | — | $243.6M | ||
| Q3 24 | — | $148.8M | ||
| Q2 24 | $61.4M | $195.7M |
自由现金流率PRMBSTE
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | 13.3% | ||
| Q3 25 | 9.5% | 13.8% | ||
| Q2 25 | 5.8% | 23.5% | ||
| Q1 25 | -1.4% | 12.8% | ||
| Q4 24 | — | 17.8% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | 4.7% | 15.3% |
资本支出强度PRMBSTE
| Q1 26 | 2.9% | — | ||
| Q4 25 | 9.4% | 6.6% | ||
| Q3 25 | 6.6% | 5.9% | ||
| Q2 25 | 3.1% | 6.7% | ||
| Q1 25 | 3.8% | 4.8% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | 3.1% | 8.4% |
现金转化率PRMBSTE
| Q1 26 | 3.80× | — | ||
| Q4 25 | — | 1.55× | ||
| Q3 25 | 16.87× | 1.50× | ||
| Q2 25 | 5.62× | 2.37× | ||
| Q1 25 | 1.35× | 1.79× | ||
| Q4 24 | — | 1.92× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | 1.88× | 2.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRMB
| Regional spring water | $801.2M | 49% |
| Purified water | $511.2M | 31% |
| Other | $208.2M | 13% |
| Premium water | $105.5M | 6% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
